Цена акции Hansoh Pharmaceutical Group Company Limited (3692) 📈: стоимость на сегодня, котировки, дивиденды за 2025 и динамика курса онлайн

Share chart Hansoh Pharmaceutical Group Company Limited

About Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited, инвестиционная холдинговая компания, занимается исследованием, разработкой, производством и продажей фармацевтической продукции в Китайской Народной Республике. Компания предоставляет продукты для терапевтических областей, в том числе противоопухолевых, противоинфекционных, заболеваний центральной нервной системы, метаболических заболеваний и других терапевтических областей.

more details

Add to compare list

Add to watchlist

Add to portfolio

Add to notification price

Main settings

ISIN

KYG549581067

Industry

Pharmaceuticals

Sector

Health Care

Валюта

hkd

Валюта отчета

cny

Див.доход ао

2.31

Дивиденд ао

0.3432

Сайт

link

All parameters

Grade

Underestimation

Title	Value	Grade
P/S	7.86	1
P/BV	3.36	5
P/E	22.04	7

Efficiency

Title	Value	Grade
ROA	13.51	4
ROE	16.05	5
ROIC	0	0

Dividends

Title	Value	Grade
Dividend yield	2.21	5.53
DSI	1	10
Average dividend growth	38.67	10

Debt

Title	Value	Grade
Debt/EBITDA	1.31	8
Debt/Ratio	0.1326	10
Debt/Equity	0.2808	10

Growth impulse

Title	Value	Grade
Yield Revenue, %	41.09	6
Yield Ebitda, %	45.16	6
Yield EPS, %	1597.47	10

	Price	Min.	Max.	Change	Changes in the industry	Changes in the index
Yesterday	27.75 HK$	0 HK$	0 HK$	0.18 %	0 %	0 %
Week	29.4 HK$	27.75 HK$	29.3 HK$	-5.44 %	0 %	0 %
Month	26.05 HK$	25.6 HK$	29.9 HK$	6.72 %	0 %	0 %
Three month	21.85 HK$	20.65 HK$	29.9 HK$	27.23 %	0 %	0 %
Half a year	18.12 HK$	16.22 HK$	29.9 HK$	53.42 %	0 %	0 %
Year	19.6 HK$	15.82 HK$	29.9 HK$	41.84 %	0 %	0 %
3 years	13.8 HK$	9.6 HK$	29.9 HK$	101.45 %	0 %	0 %
5 years	34.5 HK$	9.6 HK$	45.45 HK$	-19.42 %	0 %	0 %
10 years	0 HK$	9.6 HK$	45.45 HK$	0 %	0 %	0 %
Year to date	17.8 HK$	16.22 HK$	29.9 HK$	56.18 %	0 %	0 %

Main owners

Institutions	Volume	Share, %
Fidelity Advisor Focused Emerging Markets Fund	34 306 000	0.58
Fidelity Strategic Advisors Fidelity Emerging Markets Fund	17 134 000	0.29
Vanguard International Stock Index-Emerging Markets Stk	13 235 000	0.22
Vanguard International Stock Index-Total Intl Stock Indx	13 095 836	0.22
Fidelity Series Emerging Markets Opportunities Fund	10 250 000	0.17
iShares Core MSCI Emerging Markets ETF	10 204 000	0.17
Fidelity VIP Emerging Markets Portfolio	9 078 000	0.15
Fidelity Strategic Advisers Emerging Markets Fund	7 653 744	0.13
Fidelity Emerging Markets Discovery Fund	7 410 308	0.12
iShares MSCI China ETF	3 556 000	0.06

Contained in ETF

	1.13	8,303.42	0.49
ETF	Share, %	Profitability for 1 year, %	Commission, %
Loncar China BioPharma ETF	2.19	16603.7	0.79
Xtrackers MSCI Emerging Markets ESG Leaders Equity ETF	0.07086	3.13	0.20

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda

Company management

Head	Job title	Payment	Year of birth
Ms. Huijuan Zhong	Chairlady, CEO & President	12.07M	1961 (64 years)
Mr. Min Hu	VP & CFO	N/A	1977 (48 years)
Ms. Yuan Sun	Executive Director	7.43M	1987 (38 years)
Mr. Chuanhe Xu	Senior Vice President	N/A	1964 (61 year)
Mr. Weiyong Sun	Chief Commercial Officer	N/A	1971 (54 years)
Dr. Aifeng Lyu	Executive Director		1977 (48 years)
Dr. Chih-Hung Lee	Chief of Science Officer		1960 (65 years)
Ms. Shengli Zhong	Joint Company Secretary & Senior VP		1968 (57 years)
Ms. Sze Wai Tam	Joint Company Secretary

About company

Address: China, Shanghai, 287 Xiangke Road - Open in google maps, Open in yandex maps
Website: https://www.hspharm.com

Investing Port

Hansoh Pharmaceutical Group Company Limited